FOXM1 and cancer: Consistently, we found that FOXM1 was positively correlated with RNF26 in multiple types of malignant tumors, including bladder cancer, colon cancer, cervical cancer, breast cancer, prostate cancer, pancreatic cancer, liver cancer, and gastric cancer (Supplementary Fig. 1).